Medical Devices Startups
6,520 companies tagged Medical Devices, with their investors and founders.
BoundlessDx (Boundless Diagnostics) develops portable, handheld point-of-care diagnostic devices that deliver rapid results from small fluid samples for veterinary use. Its tests, including inflammation and multi-analyte panels for dogs, cats, and horses, serve animal health practitioners in the veterinary diagnostics market.
0 investors
BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.
0 investors
Brij Medical makes BRIJ-SEAL, a single-use sterile hypoallergenic wound sealant that forms a 14-day bacterial barrier over post-operative incisions, and Brijjit Force Modulating Tissue Bridges, non-invasive skin closure devices that offload incisional tension. The products are used by orthopedic, plastic, and podiatric surgeons for surgical incision management and improved wound healing.
0 investors
Bruker provides preclinical imaging solutions for research across oncology, neurology, cardiology, and other disease areas, serving academic institutions and pharmaceutical researchers.
0 investors
Bullseye Biodevices develops a multimodal biosensing platform that combines mechanical, electrical, and optical sensing to assess tissue and organ condition in real time. The technology targets medical applications including tumor localization and surgical margin assessment, skin health monitoring, and organ evaluation during surgery, preservation, and transplantation.
0 investors
BURL Concepts develops SONAS ultrasound technology, a portable, non-invasive tool that uses a contrast solution to assess and monitor cerebral blood flow at the bedside. It is designed for clinicians in hospital and non-hospital settings to evaluate brain perfusion and guide treatment for stroke and other neurological trauma patients.
0 investors
A medical facility in New Jersey providing endoscopic services and gastroenterology care to ambulatory patients in local communities.
0 investors
C2N Diagnostics develops and commercializes blood-based diagnostic tests for Alzheimer's disease and other neurodegenerative conditions, using proprietary LC-MS/MS mass spectrometry to detect brain amyloid pathology. Its PrecivityAD, PrecivityAD2, and Precivity-ApoE tests serve health care professionals evaluating patients with cognitive impairment, available across all 50 US states and the District of Columbia.
0 investors
C4 Imaging develops the SIRIUS MRI Marker, a device for precise localization of implanted LDR seeds in MRI imaging to support post-implant quality assurance in brachytherapy treatments. The product helps ensure accurate treatment delivery and protects critical anatomical structures during radiation therapy procedures.
0 investors
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company developing anticoagulation and antithrombotic therapies for cardiovascular and thrombotic disorders. Its pipeline includes CAD-1005, a first-in-class 12-LOX inhibitor for heparin-induced thrombocytopenia, tecarfarin for end-stage kidney disease and LVAD patients, and frunexian, an intravenous Factor XIa inhibitor for acute/critical care settings.</parameter> <parameter name="founders">[]
0 investors
Caira Surgical develops joint replacement software, 3D scanning, and radar-based tracking technologies for orthopedic surgeons, with its first product being a navigation system for knee replacement. Its products are still in development and not yet marketed or registered.
0 investors
Caliber I.D. (Caliber Imaging & Diagnostics) develops medical imaging products, including the VivaScope, VivaNet, VivaCam and VivaScan lines, for diagnostic use.
0 investors
Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
0 investors
Canal Biosciences develops DNA library preparation technology for next-generation sequencing, centered on its TrueLink platform and DISTAL-seq products that attach sequencing adaptors to native DNA termini without end repair to preserve template integrity. Its methods target high-precision NGS applications such as liquid biopsy, methylation sequencing, and minimal residual disease detection in cancer.
0 investors
CancerVax develops cancer therapeutics using lipid nanoparticle technology in partnership with Cytiva. The company is focused on creating nanoparticle-based treatments for cancer patients.
0 investors
Cannabinoid API Solutions distributes pharmaceutical-grade hemp-derived cannabinoid active pharmaceutical ingredients to pharmaceutical companies conducting clinical and commercial activities. The company partners with 22nd Century Group and GVB Biopharma, which manufacture isolate-form APIs including CBD, CBG, CBN, and other minor cannabinoids.
0 investors
Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.
0 investors
Captiva Spine manufactures medical implants, specifically the TransFasten-LSF system, a minimally invasive lateral sacroiliac joint fusion device for orthopedic spine surgery.
0 investors
Cardiff Lexington is a diversified healthcare holding company that acquires and operates businesses providing medical diagnostic and therapeutic services. It focuses on growth through strategic acquisitions of companies within the healthcare segment aimed at improving patient outcomes.
0 investors
CardioFlow develops medical devices for interventional cardiology, specifically addressing critical limb-threatening ischemia through non-surgical therapies. The company serves interventional cardiologists and cardiovascular specialists.
0 investors
CareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
0 investors
Carolina Molecular Instruments provides whole genome sequencing and genomic testing services for agricultural research, crop quality control, soil health assessment, and food safety applications. The company delivers strain-level pathogen identification and contamination detection for agricultural products and food science industries.
0 investors
Ceek Women's Health designs modern speculums and gynecological exam tools, including Nella, a reusable and single-use speculum line with integrated sidewall retractors intended to improve clinician efficiency and patient comfort. Its products are aimed at clinicians and women undergoing pelvic and cervical exams.
0 investors
CEL-SCI Corporation is a biotech company developing immunotherapies, particularly Multikine, which is advancing through FDA regulatory processes. The company is focused on cancer treatment and has progressed to Phase 3 clinical trials.
0 investors